These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16940107)

  • 21. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
    Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
    Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.
    Villegas MV; Lolans K; Correa A; Kattan JN; Lopez JA; Quinn JP;
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1553-5. PubMed ID: 17261621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation of Escherichia coli ST131 producing KPC-2 in Bulgaria.
    Markovska R; Stoeva T; Boyanova L; Stankova P; Pencheva D; Kaneva R; Mitev V; Mitov I
    Infect Dis (Lond); 2017 May; 49(5):429-431. PubMed ID: 28049378
    [No Abstract]   [Full Text] [Related]  

  • 24. In vivo development of carbapenem resistance in clinical isolates of Enterobacter aerogenes producing multiple beta-lactamases.
    Chen YG; Zhang Y; Yu YS; Qu TT; Wei ZQ; Shen P; Li LJ
    Int J Antimicrob Agents; 2008 Oct; 32(4):302-7. PubMed ID: 18556176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
    Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
    J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KPC-2 β-lactamase enables carbapenem antibiotic resistance through fast deacylation of the covalent intermediate.
    Mehta SC; Furey IM; Pemberton OA; Boragine DM; Chen Y; Palzkill T
    J Biol Chem; 2021; 296():100155. PubMed ID: 33273017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Escherichia coli: development of carbapenem resistance during therapy.
    Hong T; Moland ES; Abdalhamid B; Hanson ND; Wang J; Sloan C; Fabian D; Farajallah A; Levine J; Thomson KS
    Clin Infect Dis; 2005 May; 40(10):e84-6. PubMed ID: 15844056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York.
    Bratu S; Brooks S; Burney S; Kochar S; Gupta J; Landman D; Quale J
    Clin Infect Dis; 2007 Apr; 44(7):972-5. PubMed ID: 17342651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of aac(6')-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel.
    Chmelnitsky I; Hermesh O; Navon-Venezia S; Strahilevitz J; Carmeli Y
    J Antimicrob Chemother; 2009 Oct; 64(4):718-22. PubMed ID: 19656782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
    Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
    J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbapenem-hydrolysing metallo-beta-lactamases from Klebsiella pneumoniae and Escherichia coli isolated in Australia.
    Poirel L; Pham JN; Cabanne L; Gatus BJ; Bell SM; Nordmann P
    Pathology; 2004 Aug; 36(4):366-7. PubMed ID: 15370141
    [No Abstract]   [Full Text] [Related]  

  • 32. Cloning and sequencing of the class A beta-lactamase gene (blaTEM-15) located on a chromosomal Tn801 transposon.
    Chouchani C; Ben-Achour N; M'Charek A; Belhadj O
    Diagn Microbiol Infect Dis; 2007 Aug; 58(4):459-63. PubMed ID: 17449209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
    Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS
    J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of resistance and mobility among multidrug-resistant CTX-M-producing Escherichia coli from Canadian intensive care units: the 1st report of QepA in North America.
    Baudry PJ; Nichol K; DeCorby M; Lagacé-Wiens P; Olivier E; Boyd D; Mulvey MR; Hoban DJ; Zhanel GG
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):319-26. PubMed ID: 19216943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of carbapenem resistant plasmid isolated from Serratia marcescens].
    Yosue T
    Fukuoka Igaku Zasshi; 1996 May; 87(5):116-26. PubMed ID: 8690335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CMY-20, a novel AmpC-type beta-lactamase from South African clinical Escherichia coli isolates.
    Mocktar C; Govinden U; Sturm AW; Essack SY
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):405-8. PubMed ID: 18207348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbapenem-resistant Escherichia coli carrying the blaVIM-1 gene in the community.
    Vitti D; Protonotariou E; Sofianou D
    Int J Antimicrob Agents; 2009 Aug; 34(2):187-8. PubMed ID: 19324525
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasmid-mediated carbapenem-hydrolysing beta-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China.
    Zhang R; Zhou HW; Cai JC; Chen GX
    J Antimicrob Chemother; 2007 Mar; 59(3):574-6. PubMed ID: 17251347
    [No Abstract]   [Full Text] [Related]  

  • 39. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan.
    Nadkarni AS; Schliep T; Khan L; Zeana CB
    Am J Infect Control; 2009 Mar; 37(2):121-6. PubMed ID: 19249638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First detection of a VIM-1 metallo-beta-lactamase in a carbapenem-resistant Citrobacter freundii clinical isolate in an acute hospital in Germany.
    Weile J; Rahmig H; Gfröer S; Schroeppel K; Knabbe C; Susa M
    Scand J Infect Dis; 2007; 39(3):264-6. PubMed ID: 17366062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.